MOUNTAIN VIEW, CA and TOKYO -- (MARKET WIRE) -- February 21, 2007 -- REGiMMUNE Corporation., a privately held biopharmaceutical company, announced today the appointment of Shirley Liu Clayton as a non-executive director. Ms. Clayton recently retired as President and Chief Executive Officer of Abmaxis, Inc., which was acquired by Merck & Co. in 2006.
